Cambridge, MA, United States of America

Evan R Daugharthy

This inventor holds 26 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Nucleic Acid Detection. Top assignees: Harvard College, Massachusetts Institute of Technology, Readcoor, LLC. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evan R Daugharthy. Retrieved from https://idiyas.com/inventor/evan-r-daugharthy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 96.2

 

 

Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 993(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Sequencing
Biomolecule Detection
Spatial Mapping
High-Throughput Labeling
Fluorescent In Situ Sequencing
Volumetric Imaging
Three-Dimensional Imaging
Microscopy Techniques
Genomic Variants
Hybridization Chain Reaction
Biological Assays
Nanoscale Imaging
26 patents (USPTO):Explore Patents

Title: Evan R Daugharthy: Innovator in Molecular Biology

Introduction

Evan R Daugharthy is a prominent inventor based in Cambridge, MA, renowned for his significant contributions to molecular biology and genetics. With a total of 22 patents to his name, Daugharthy has been instrumental in developing advanced methodologies that enhance our understanding of genetic variants.

Latest Patents

Among his latest patented innovations are two groundbreaking technologies. The first, titled "Methods and systems for spatial mapping of genetic variants," provides comprehensive methodologies for analyzing biological samples from subjects. This process uses specific probes to accurately identify and determine the locations of various genetic sequences within a sample.

The second innovation is "Three-dimensional spatial molecular indexing," which outlines methods for generating and utilizing indices within a synthetic three-dimensional (3D) matrix from biological samples. This patent describes a meticulous process that incorporates the use of a transposase to insert a nucleic acid index sequence into nucleic acid molecules, allowing for the detection of their 3D spatial positions and enabling further analysis.

Career Highlights

Evan Daugharthy has had a distinguished career, holding influential positions at prestigious institutions such as Harvard University and the Massachusetts Institute of Technology (MIT). His work has elevated the standards of research and innovation in the biological sciences, particularly in the mapping and indexing of genetic materials.

Collaborations

Throughout his career, Daugharthy has collaborated with esteemed colleagues, including notable figures such as George M. Church and Richard C. Terry. These partnerships have not only facilitated groundbreaking research but have also contributed to the advancement of technologies that play a critical role in genetic analysis and molecular biology.

Conclusion

Evan R Daugharthy's contributions to the field of molecular biology through his inventive solutions and collaborative efforts underscore his importance as an innovator. His 22 patents reflect a dedication to advancing genetic research and analysis, paving the way for future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…